Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
GLUE

Updated 10/6/2026, 9:41 AM ET.

GLUE

Monte Rosa Therapeutics, Inc.

Sale$220,219

Warmuth Markus

President & CEO, Director

9,500 shat $23.18Filed Jul 17, 4:05 PM ETFiling
GLUE

Monte Rosa Therapeutics, Inc.

Sale$101,730

Champoux Jennifer

Chief Operating Officer

4,351 shat $23.38Filed Jul 16, 4:10 PM ET
Filing

Read from public SEC filings. Not financial advice.